Recalls

Baxter Issues Urgent Nationwide Voluntary Recall of Heparin
01/29/2008

The U.S. Food and Drug Administration reports: Baxter Healthcare Corporation has announced the voluntary recall of nine lots of heparin sodium injection 100 units/ml 10 ml and 30 ml multi-dose vials. The company began recalling the lots on January 17, 2008 as a precautionary measure due to an increase in the number of repots of adverse patient reactions that may be associated with the product. Baxter is conducting a thorough investigation of these reports to identify the cause of the increase in allergic-type reactions.